E-Cadherin Expression in Endometrial Malignancies: Comparison between Endometrioid and Non-Endometrioid Carcinomas
This study examined the frequency of E-cadherin expression in endometrial biopsy or hysterectomy specimens from patients diagnosed with endometrial adenocarcinoma and in normal endometrial tissue specimens. E-cadherin expression was detected by immunohistochemistry using monoclonal antibody to E-cad...
Gespeichert in:
Veröffentlicht in: | Journal of international medical research 2009-01, Vol.37 (1), p.163-168 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 168 |
---|---|
container_issue | 1 |
container_start_page | 163 |
container_title | Journal of international medical research |
container_volume | 37 |
creator | Yalta, T Atay, L Atalay, F Çaydere, M Gonultas, M Ustun, H |
description | This study examined the frequency of E-cadherin expression in endometrial biopsy or hysterectomy specimens from patients diagnosed with endometrial adenocarcinoma and in normal endometrial tissue specimens. E-cadherin expression was detected by immunohistochemistry using monoclonal antibody to E-cadherin. Specimens were classified as positive when ≥ 5% of the tumour cells showed staining for E-cadherin, irrespective of the pattern of staining. Twenty-three endometrioid carcinomas and nine non-endometrioid (four papillary serous and five clear cell) carcinomas were studied, along with 10 normal endometrial tissue specimens as controls. E-cadherin expression was significantly less frequent in non-endometrioid carcinomas compared with endometrioid carcinomas and controls. There was no statistically significant difference in the frequency of E-cadherin expression between endometrioid carcinomas and controls. In conclusion, this study demonstrated that uterine non-endometrioid (papillary serous and clear cell) carcinomas were less likely to express E-cadherin compared with endometrioid carcinomas and normal endometrial tissue. This may help to explain the more aggressive behaviour of non-endometrioid carcinomas. |
doi_str_mv | 10.1177/147323000903700119 |
format | Article |
fullrecord | <record><control><sourceid>proquest_AFRWT</sourceid><recordid>TN_cdi_proquest_miscellaneous_66918700</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sage_id>10.1177_147323000903700119</sage_id><sourcerecordid>66918700</sourcerecordid><originalsourceid>FETCH-LOGICAL-c341t-64baeed538460af1b216f06f363e186a69571a3e52b12fe737f51d22b2a89b9a3</originalsourceid><addsrcrecordid>eNp9kEtLw0AUhQdRbK3-AReSlbvYuTPJJHEnoT7Ax0bX4Sa5qVOSmTjToP57U1pQEVwd7uE7B-5h7BT4BUCSzCFKpJCc84zLhHOAbI9NN2a4cffZlI8ScsXjCTvyfsV5JFQsDtkEMgGxStWUuUWYY_1KTptg8dE78l5bE2wuU9uO1k5jGzxgq5cGTaXJXwa57Xp02o9cSet3oh-w1XWApg4erQl_mTm6ShvboT9mBw22nk52OmMv14vn_Da8f7q5y6_uw0pGsA5VVCJRHcs0UhwbKAWohqtGKkmQKlRZnABKikUJoqFEJk0MtRClwDQrM5Qzdr7t7Z19G8ivi077itoWDdnBF0plkI67jaDYgpWz3jtqit7pDt1nAbzYLF38XXoMne3ah7Kj-juym3YE5lvA45KKlR2cGb_9r_IL0xyHDg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>66918700</pqid></control><display><type>article</type><title>E-Cadherin Expression in Endometrial Malignancies: Comparison between Endometrioid and Non-Endometrioid Carcinomas</title><source>Sage Journals GOLD Open Access 2024</source><creator>Yalta, T ; Atay, L ; Atalay, F ; Çaydere, M ; Gonultas, M ; Ustun, H</creator><creatorcontrib>Yalta, T ; Atay, L ; Atalay, F ; Çaydere, M ; Gonultas, M ; Ustun, H</creatorcontrib><description>This study examined the frequency of E-cadherin expression in endometrial biopsy or hysterectomy specimens from patients diagnosed with endometrial adenocarcinoma and in normal endometrial tissue specimens. E-cadherin expression was detected by immunohistochemistry using monoclonal antibody to E-cadherin. Specimens were classified as positive when ≥ 5% of the tumour cells showed staining for E-cadherin, irrespective of the pattern of staining. Twenty-three endometrioid carcinomas and nine non-endometrioid (four papillary serous and five clear cell) carcinomas were studied, along with 10 normal endometrial tissue specimens as controls. E-cadherin expression was significantly less frequent in non-endometrioid carcinomas compared with endometrioid carcinomas and controls. There was no statistically significant difference in the frequency of E-cadherin expression between endometrioid carcinomas and controls. In conclusion, this study demonstrated that uterine non-endometrioid (papillary serous and clear cell) carcinomas were less likely to express E-cadherin compared with endometrioid carcinomas and normal endometrial tissue. This may help to explain the more aggressive behaviour of non-endometrioid carcinomas.</description><identifier>ISSN: 0300-0605</identifier><identifier>EISSN: 1473-2300</identifier><identifier>DOI: 10.1177/147323000903700119</identifier><identifier>PMID: 19215686</identifier><language>eng</language><publisher>London, England: SAGE Publications</publisher><subject>Cadherins - metabolism ; Case-Control Studies ; Endometrial Neoplasms - classification ; Endometrial Neoplasms - metabolism ; Endometrial Neoplasms - pathology ; Endometrium - metabolism ; Female ; Humans</subject><ispartof>Journal of international medical research, 2009-01, Vol.37 (1), p.163-168</ispartof><rights>2009 SAGE Publications</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c341t-64baeed538460af1b216f06f363e186a69571a3e52b12fe737f51d22b2a89b9a3</citedby><cites>FETCH-LOGICAL-c341t-64baeed538460af1b216f06f363e186a69571a3e52b12fe737f51d22b2a89b9a3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://journals.sagepub.com/doi/pdf/10.1177/147323000903700119$$EPDF$$P50$$Gsage$$H</linktopdf><linktohtml>$$Uhttps://journals.sagepub.com/doi/10.1177/147323000903700119$$EHTML$$P50$$Gsage$$H</linktohtml><link.rule.ids>314,780,784,21965,27852,27923,27924,44944,45332</link.rule.ids><linktorsrc>$$Uhttps://journals.sagepub.com/doi/full/10.1177/147323000903700119?utm_source=summon&utm_medium=discovery-provider$$EView_record_in_SAGE_Publications$$FView_record_in_$$GSAGE_Publications</linktorsrc><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19215686$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Yalta, T</creatorcontrib><creatorcontrib>Atay, L</creatorcontrib><creatorcontrib>Atalay, F</creatorcontrib><creatorcontrib>Çaydere, M</creatorcontrib><creatorcontrib>Gonultas, M</creatorcontrib><creatorcontrib>Ustun, H</creatorcontrib><title>E-Cadherin Expression in Endometrial Malignancies: Comparison between Endometrioid and Non-Endometrioid Carcinomas</title><title>Journal of international medical research</title><addtitle>J Int Med Res</addtitle><description>This study examined the frequency of E-cadherin expression in endometrial biopsy or hysterectomy specimens from patients diagnosed with endometrial adenocarcinoma and in normal endometrial tissue specimens. E-cadherin expression was detected by immunohistochemistry using monoclonal antibody to E-cadherin. Specimens were classified as positive when ≥ 5% of the tumour cells showed staining for E-cadherin, irrespective of the pattern of staining. Twenty-three endometrioid carcinomas and nine non-endometrioid (four papillary serous and five clear cell) carcinomas were studied, along with 10 normal endometrial tissue specimens as controls. E-cadherin expression was significantly less frequent in non-endometrioid carcinomas compared with endometrioid carcinomas and controls. There was no statistically significant difference in the frequency of E-cadherin expression between endometrioid carcinomas and controls. In conclusion, this study demonstrated that uterine non-endometrioid (papillary serous and clear cell) carcinomas were less likely to express E-cadherin compared with endometrioid carcinomas and normal endometrial tissue. This may help to explain the more aggressive behaviour of non-endometrioid carcinomas.</description><subject>Cadherins - metabolism</subject><subject>Case-Control Studies</subject><subject>Endometrial Neoplasms - classification</subject><subject>Endometrial Neoplasms - metabolism</subject><subject>Endometrial Neoplasms - pathology</subject><subject>Endometrium - metabolism</subject><subject>Female</subject><subject>Humans</subject><issn>0300-0605</issn><issn>1473-2300</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kEtLw0AUhQdRbK3-AReSlbvYuTPJJHEnoT7Ax0bX4Sa5qVOSmTjToP57U1pQEVwd7uE7B-5h7BT4BUCSzCFKpJCc84zLhHOAbI9NN2a4cffZlI8ScsXjCTvyfsV5JFQsDtkEMgGxStWUuUWYY_1KTptg8dE78l5bE2wuU9uO1k5jGzxgq5cGTaXJXwa57Xp02o9cSet3oh-w1XWApg4erQl_mTm6ShvboT9mBw22nk52OmMv14vn_Da8f7q5y6_uw0pGsA5VVCJRHcs0UhwbKAWohqtGKkmQKlRZnABKikUJoqFEJk0MtRClwDQrM5Qzdr7t7Z19G8ivi077itoWDdnBF0plkI67jaDYgpWz3jtqit7pDt1nAbzYLF38XXoMne3ah7Kj-juym3YE5lvA45KKlR2cGb_9r_IL0xyHDg</recordid><startdate>20090101</startdate><enddate>20090101</enddate><creator>Yalta, T</creator><creator>Atay, L</creator><creator>Atalay, F</creator><creator>Çaydere, M</creator><creator>Gonultas, M</creator><creator>Ustun, H</creator><general>SAGE Publications</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20090101</creationdate><title>E-Cadherin Expression in Endometrial Malignancies: Comparison between Endometrioid and Non-Endometrioid Carcinomas</title><author>Yalta, T ; Atay, L ; Atalay, F ; Çaydere, M ; Gonultas, M ; Ustun, H</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c341t-64baeed538460af1b216f06f363e186a69571a3e52b12fe737f51d22b2a89b9a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Cadherins - metabolism</topic><topic>Case-Control Studies</topic><topic>Endometrial Neoplasms - classification</topic><topic>Endometrial Neoplasms - metabolism</topic><topic>Endometrial Neoplasms - pathology</topic><topic>Endometrium - metabolism</topic><topic>Female</topic><topic>Humans</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Yalta, T</creatorcontrib><creatorcontrib>Atay, L</creatorcontrib><creatorcontrib>Atalay, F</creatorcontrib><creatorcontrib>Çaydere, M</creatorcontrib><creatorcontrib>Gonultas, M</creatorcontrib><creatorcontrib>Ustun, H</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of international medical research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Yalta, T</au><au>Atay, L</au><au>Atalay, F</au><au>Çaydere, M</au><au>Gonultas, M</au><au>Ustun, H</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>E-Cadherin Expression in Endometrial Malignancies: Comparison between Endometrioid and Non-Endometrioid Carcinomas</atitle><jtitle>Journal of international medical research</jtitle><addtitle>J Int Med Res</addtitle><date>2009-01-01</date><risdate>2009</risdate><volume>37</volume><issue>1</issue><spage>163</spage><epage>168</epage><pages>163-168</pages><issn>0300-0605</issn><eissn>1473-2300</eissn><abstract>This study examined the frequency of E-cadherin expression in endometrial biopsy or hysterectomy specimens from patients diagnosed with endometrial adenocarcinoma and in normal endometrial tissue specimens. E-cadherin expression was detected by immunohistochemistry using monoclonal antibody to E-cadherin. Specimens were classified as positive when ≥ 5% of the tumour cells showed staining for E-cadherin, irrespective of the pattern of staining. Twenty-three endometrioid carcinomas and nine non-endometrioid (four papillary serous and five clear cell) carcinomas were studied, along with 10 normal endometrial tissue specimens as controls. E-cadherin expression was significantly less frequent in non-endometrioid carcinomas compared with endometrioid carcinomas and controls. There was no statistically significant difference in the frequency of E-cadherin expression between endometrioid carcinomas and controls. In conclusion, this study demonstrated that uterine non-endometrioid (papillary serous and clear cell) carcinomas were less likely to express E-cadherin compared with endometrioid carcinomas and normal endometrial tissue. This may help to explain the more aggressive behaviour of non-endometrioid carcinomas.</abstract><cop>London, England</cop><pub>SAGE Publications</pub><pmid>19215686</pmid><doi>10.1177/147323000903700119</doi><tpages>6</tpages></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | ISSN: 0300-0605 |
ispartof | Journal of international medical research, 2009-01, Vol.37 (1), p.163-168 |
issn | 0300-0605 1473-2300 |
language | eng |
recordid | cdi_proquest_miscellaneous_66918700 |
source | Sage Journals GOLD Open Access 2024 |
subjects | Cadherins - metabolism Case-Control Studies Endometrial Neoplasms - classification Endometrial Neoplasms - metabolism Endometrial Neoplasms - pathology Endometrium - metabolism Female Humans |
title | E-Cadherin Expression in Endometrial Malignancies: Comparison between Endometrioid and Non-Endometrioid Carcinomas |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-13T07%3A41%3A32IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_AFRWT&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=E-Cadherin%20Expression%20in%20Endometrial%20Malignancies:%20Comparison%20between%20Endometrioid%20and%20Non-Endometrioid%20Carcinomas&rft.jtitle=Journal%20of%20international%20medical%20research&rft.au=Yalta,%20T&rft.date=2009-01-01&rft.volume=37&rft.issue=1&rft.spage=163&rft.epage=168&rft.pages=163-168&rft.issn=0300-0605&rft.eissn=1473-2300&rft_id=info:doi/10.1177/147323000903700119&rft_dat=%3Cproquest_AFRWT%3E66918700%3C/proquest_AFRWT%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=66918700&rft_id=info:pmid/19215686&rft_sage_id=10.1177_147323000903700119&rfr_iscdi=true |